DK3484467T3 - Kombination af rene 5-ht6-receptorantagonister med acetylcholinesterasehæmmere - Google Patents
Kombination af rene 5-ht6-receptorantagonister med acetylcholinesterasehæmmere Download PDFInfo
- Publication number
- DK3484467T3 DK3484467T3 DK16766622.1T DK16766622T DK3484467T3 DK 3484467 T3 DK3484467 T3 DK 3484467T3 DK 16766622 T DK16766622 T DK 16766622T DK 3484467 T3 DK3484467 T3 DK 3484467T3
- Authority
- DK
- Denmark
- Prior art keywords
- pure
- combination
- receptor antagonists
- acetyl choline
- inhibitors
- Prior art date
Links
- 108091005435 5-HT6 receptors Proteins 0.000 title 1
- 239000000544 cholinesterase inhibitor Substances 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/305—Mercury compounds
- A61K31/31—Mercury compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201641017205 | 2016-05-18 | ||
| PCT/IB2016/054673 WO2017199071A1 (en) | 2016-05-18 | 2016-08-03 | Combination of pure 5-ht6 receptor antagonists with acetylcholinesterase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3484467T3 true DK3484467T3 (da) | 2020-06-08 |
Family
ID=56940098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16766622.1T DK3484467T3 (da) | 2016-05-18 | 2016-08-03 | Kombination af rene 5-ht6-receptorantagonister med acetylcholinesterasehæmmere |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US11458135B2 (da) |
| EP (1) | EP3484467B1 (da) |
| JP (1) | JP6606299B2 (da) |
| KR (1) | KR102015484B1 (da) |
| CN (2) | CN109069468A (da) |
| AU (1) | AU2016407427B2 (da) |
| BR (1) | BR112018073419A2 (da) |
| CA (1) | CA3023819C (da) |
| CY (1) | CY1123013T1 (da) |
| DK (1) | DK3484467T3 (da) |
| EA (1) | EA036347B1 (da) |
| ES (1) | ES2796181T3 (da) |
| HR (1) | HRP20200872T1 (da) |
| HU (1) | HUE050819T2 (da) |
| IL (1) | IL262921B (da) |
| LT (1) | LT3484467T (da) |
| MA (1) | MA45639B1 (da) |
| MD (1) | MD3484467T2 (da) |
| ME (1) | ME03731B (da) |
| MX (1) | MX381768B (da) |
| NZ (1) | NZ748280A (da) |
| PL (1) | PL3484467T3 (da) |
| PT (1) | PT3484467T (da) |
| RS (1) | RS60422B1 (da) |
| SG (1) | SG11201809856SA (da) |
| SI (1) | SI3484467T1 (da) |
| SM (1) | SMT202000292T1 (da) |
| WO (1) | WO2017199071A1 (da) |
| ZA (1) | ZA201807468B (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111084768A (zh) * | 2018-10-24 | 2020-05-01 | 中国科学院昆明动物研究所 | 吉非罗齐及其衍生物用于治疗和/或预防神经退行性疾病的用途 |
| CN111084776A (zh) * | 2018-10-24 | 2020-05-01 | 中国科学院昆明动物研究所 | 匹立尼酸及其衍生物用于治疗和/或预防神经退行性疾病的用途 |
| US20220409614A1 (en) * | 2019-12-02 | 2022-12-29 | Suven Life Sciences Limited | Treating behavioral and psychological symptoms in dementia patients |
| MA57828B1 (fr) * | 2019-12-02 | 2025-09-30 | Suven Life Sciences Limited | Combinaisons du masupirdine avec du donépézil ou de la mémantine pour le traitement de symptômes comportementaux et psychologiques chez des patients atteints de démence |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7875605B2 (en) * | 2002-11-28 | 2011-01-25 | Suven Life Sciences Limited | N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| SI1581538T1 (sl) * | 2002-12-18 | 2007-08-31 | Suven Life Sciences Ltd | Tetraciklični 3-substituirani indoli z afiniteto za receptor serotonina |
| PE20071143A1 (es) | 2006-01-13 | 2008-01-20 | Wyeth Corp | Composicion farmaceutica que comprende un inhibidor de acetilcolinesterasa y un antagonista 5-hidroxitriptamina-6 |
| WO2007147883A1 (en) | 2006-06-23 | 2007-12-27 | Laboratorios Del Dr. Esteve, S.A. | Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity |
| AR061637A1 (es) | 2006-06-26 | 2008-09-10 | Epix Delaware Inc | Composiciones y metodos de tratamiento de trastornos del snc |
| JO3459B1 (ar) | 2012-09-09 | 2020-07-05 | H Lundbeck As | تركيبات صيدلانية لعلاج مرض الزهايمر |
| AU2014358682B2 (en) | 2013-12-02 | 2016-10-20 | Suven Life Sciences Limited | Process for large scale production of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrate |
| DK3180001T3 (da) * | 2014-08-16 | 2019-04-01 | Suven Life Sciences Ltd | Aktiv metabolit af 1-[(2-bromphenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1h-indol-dimesylat-monohydrat og dimesylat-dihydratsalt af aktivt metabolit |
-
2016
- 2016-08-03 NZ NZ748280A patent/NZ748280A/en unknown
- 2016-08-03 MD MDE20190594T patent/MD3484467T2/ro unknown
- 2016-08-03 AU AU2016407427A patent/AU2016407427B2/en active Active
- 2016-08-03 SM SM20200292T patent/SMT202000292T1/it unknown
- 2016-08-03 CN CN201680085574.0A patent/CN109069468A/zh active Pending
- 2016-08-03 ME MEP-2020-109A patent/ME03731B/me unknown
- 2016-08-03 PT PT167666221T patent/PT3484467T/pt unknown
- 2016-08-03 CA CA3023819A patent/CA3023819C/en active Active
- 2016-08-03 ES ES16766622T patent/ES2796181T3/es active Active
- 2016-08-03 WO PCT/IB2016/054673 patent/WO2017199071A1/en not_active Ceased
- 2016-08-03 MA MA45639A patent/MA45639B1/fr unknown
- 2016-08-03 US US16/099,161 patent/US11458135B2/en active Active
- 2016-08-03 LT LTEP16766622.1T patent/LT3484467T/lt unknown
- 2016-08-03 KR KR1020187035983A patent/KR102015484B1/ko active Active
- 2016-08-03 PL PL16766622T patent/PL3484467T3/pl unknown
- 2016-08-03 SG SG11201809856SA patent/SG11201809856SA/en unknown
- 2016-08-03 JP JP2018559336A patent/JP6606299B2/ja active Active
- 2016-08-03 BR BR112018073419-5A patent/BR112018073419A2/pt not_active Application Discontinuation
- 2016-08-03 RS RS20200635A patent/RS60422B1/sr unknown
- 2016-08-03 HR HRP20200872TT patent/HRP20200872T1/hr unknown
- 2016-08-03 HU HUE16766622A patent/HUE050819T2/hu unknown
- 2016-08-03 DK DK16766622.1T patent/DK3484467T3/da active
- 2016-08-03 CN CN202210321209.2A patent/CN114642667A/zh active Pending
- 2016-08-03 SI SI201630791T patent/SI3484467T1/sl unknown
- 2016-08-03 EA EA201892529A patent/EA036347B1/ru unknown
- 2016-08-03 EP EP16766622.1A patent/EP3484467B1/en active Active
- 2016-08-03 MX MX2018014185A patent/MX381768B/es unknown
-
2018
- 2018-11-07 ZA ZA2018/07468A patent/ZA201807468B/en unknown
- 2018-11-11 IL IL262921A patent/IL262921B/en active IP Right Grant
-
2020
- 2020-05-29 CY CY20201100489T patent/CY1123013T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3371171T3 (da) | Inhibitorer af RET | |
| DK3204378T6 (da) | N-pyridinylacetamidderivater som hæmmere af wnt-signaleringsbanen | |
| DK3160956T3 (da) | Inhibitorer af lysin-specifik demethylase-1 | |
| DK3164380T3 (da) | Hæmmere af lysinspecifik demethylase-1 | |
| DK3978483T3 (da) | Krystallinsk toluensolvat af (s)-afoxolaner | |
| DK3207043T6 (da) | Dihydropyrrolopyridin-inhibitorer af ror-gamma | |
| DK3433234T3 (da) | Allosteriske modulatorer af nicotinacetylcholinreceptorer | |
| DK3630724T3 (da) | Substituerede indolinderivater som inhibitorer af virusreplikation af denguevirus | |
| DK3436435T3 (da) | Substituerede indolderivater som inhibitorer af replikation af denguevirus | |
| DK3601225T3 (da) | Substituerede indolinderivater som inhibitorer af denguevirus-replikation | |
| DK3068776T3 (da) | Inhibitorer af replikation af influenzavira | |
| DK3220891T3 (da) | Sublingual formulering af riluzol | |
| DK3551625T3 (da) | Heterocykliske inhibitorer af mct4 | |
| DK3227325T3 (da) | Sammensætninger med selektive hæmmere af il-6-trans-signalering | |
| DK3104847T3 (da) | Hidtil ukendt anvendelse af sigma-1-receptoragonistforbindelser | |
| DK3523315T3 (da) | Inhibitor af glucocorticoidreceptor | |
| DK3256483T3 (da) | Hidtil ukendt c-3-triterpenon med omvendte c-17-amidderivater som hiv-hæmmere patentkrav | |
| DK3418273T3 (da) | Derivater af flavagliner | |
| IL260004A (en) | Crystalline forms of quinolone analogs and their salts | |
| DK2910535T3 (da) | Sammensætning til anvendelse af ekspanderet perlit | |
| DK3826983T3 (da) | Anvendelse af substituerede 2-thiazoliner som nitrificeringshæmmere | |
| DK3430004T3 (da) | Faststofformer af nilotinibsalte | |
| DK3173071T3 (da) | Formularing af maropitant | |
| DK3630725T3 (da) | Krystallinsk form af n-butyldeoxygalactonojirimycin | |
| ME03731B (me) | Kombinacjja čistih antagonjsta 5-ht6 receptora sa inhibitorima acetilholinesteraze |